ADMIT
ADMIT - Advanced Medical Physics in Imaging and Therapy
Cancer and neurodegenerative diseases are increasing and may soon become leading causes of death in industrialized countries. With imaging procedures used widely for diagnosis and half of cancer patients undergoing radiotherapy, there's an urgent need for research to develop and quickly implement new diagnostic and therapeutic solutions.
The LOEWE Research Cluster ADMIT aims to combine advanced imaging and computer-aided procedures with new therapeutic strategies for early diagnosis and effective treatment of these diseases. By integrating expertise in radiology, oncology, and neurology, ADMIT focuses on improving image-guided therapy through innovative approaches.
ADMIT brings together researchers from the University of Applied Sciences (THM), Philipps University Marburg (UMR), and Justus Liebig University Giessen (JLU), along with clinical, corporate, and international academic partners.
The workgroup Brinkmann is involved in Project Area A, which deals with range modulators and neutrons in particle therapy with protons in particular during FLASH irradiation.
FLASH irradiation is a promising method for sparing healthy tissue during high-energy ionizing radiation treatments, but it poses a risk of secondary malignancies due to neutron exposure. This project aims to measure and analyze neutron exposure during FLASH irradiation with protons and 12C ions using advanced dosimetry and simulation techniques. The goal is to optimize safety and effectiveness, providing crucial data for improving FLASH irradiation practices.